ONDANSETRON KABI 2 mg/ml, solution for injection 10 ampoules of 4 ml
Active ingredients: Ondansetron, Ondansetron hydrochloride hydrate
Commercialized according to BDPMDispensing in France: Prescription only
Solution for injection10 ampoules of 4 mlintraveineuse
No current ANSM shortage notice is included
Package details
Original BDPM fields are shown in French.
- Official name
- ONDANSETRON KABI 2 mg/ml, solution injectable
- Pharmaceutical form
- solution injectable
- Route of administration
- intraveineuse
- Presentation description
- 10 ampoule(s) en verre de 4 ml
- Marketing authorisation holder
- FRESENIUS KABI FRANCE
- Reimbursement according to BDPM
- —
- Approval for use in healthcare institutions
- oui
- Commercialization declaration date
- 15 Dec 2011
- Prescription and dispensing conditions
- Prescription only
- List I: prescription-only medicine
- Enhanced ANSM monitoring
- No
BDPM identifiers
CIS
61271062CIP75779614CIP133400957796143Composition in BDPM
| Component | Amount per unit | Source type |
|---|---|---|
| ONDANSÉTRON (CHLORHYDRATE D') DIHYDRATÉsolution | 2,50 mg · 1 ml de solution | SA |
| ONDANSÉTRONsolution | 2,00 mg · 1 ml de solution | FT |
Information is based on BDPM data and is for reference only. Consult a doctor before use.
Other packages of this medicine
The same medicine in another pack size, according to BDPM.
Similar medicines
Similar medicines are listed using the official BDPM catalog. Availability must be checked separately. Consult a doctor or pharmacist before switching medicines.